UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 23, pp. 2247 - 2257
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - complications | Acute Coronary Syndrome - complications | Angina, Unstable - complications | Diabetes Mellitus, Type 2 - mortality | Treatment Failure | Cardiovascular Diseases - epidemiology | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide-1 Receptor - agonists | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Treatment outcome | Care and treatment | Analysis | Hypoglycemic agents | Dosage and administration | Acute coronary syndrome | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Hypersensitivity | Pancreatitis | Angina | Glucose | Hypoglycemia | Morbidity | Studies | Heart rate | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Pancreas | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1 | Clinical trials | Regulatory approval | Hemoglobin | Drug dosages | Heart failure | Mortality | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The American heart journal, ISSN 0002-8703, 06/2020, Volume 224, pp. 65 - 76
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular diseases | Testosterone | Risk factors | Myocardial infarction | Plasma | Laboratories | Risk | Cardiovascular disease | Metabolic syndrome | Density | Clinical outcomes | Body mass index | Vitamin B | Atherosclerosis | Hemoglobin | Standard deviation | Lipoproteins (high density) | Heart diseases | Continuity (mathematics) | Hypertension | Cerebral infarction | Stroke | Mortality | Diabetes mellitus | Simvastatin | Health risks | Triglycerides | Angina pectoris | Coronary artery disease | Cholesterol | Studies | Androgens | Hypotheses | Statistical models | Body mass | Arteriosclerosis | Body size | Men | Death | Acute coronary syndromes | Metabolic disorders | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2002, Volume 288, Issue 23, pp. 2981 - 2997
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular system | Biological and medical sciences | Medical sciences | Antihypertensive agents | Pharmacology. Drug treatments | Diuretics - economics | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Lisinopril - economics | Hypertension - drug therapy | Male | Angiotensin-Converting Enzyme Inhibitors - economics | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Calcium Channel Blockers - economics | Antihypertensive Agents - economics | Chlorthalidone - therapeutic use | Double-Blind Method | Risk Factors | Chlorthalidone - economics | Proportional Hazards Models | Treatment Outcome | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Diuretics - therapeutic use | Aged | Amlodipine - economics | Hypertension | Diuretics | Evaluation | Cookery for hypertensives | Drug therapy | Thiazides | Prevention | Enzymes | Neurotransmitters | Heart attacks | Clinical trials | Lipids | Health risk assessment | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 15, pp. 1383 - 1392
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Kaplan-Meier Estimate | Hospitalization - statistics & numerical data | Mineralocorticoid Receptor Antagonists - adverse effects | Male | Heart Failure - drug therapy | Incidence | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Treatment Failure | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Aged | Spironolactone - therapeutic use | Spironolactone - adverse effects | Heart Failure - mortality | Heart failure | Prevention | Evaluation | Care and treatment | Usage | Spironolactone | Mortality | United Kingdom | Cardiac output | Creatinine | Hyperkalemia | Heart attacks | Hypokalemia | Ventricle | Drug therapy | Heart diseases | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2002, Volume 288, Issue 23, pp. 2998 - 3007
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular system | Biological and medical sciences | Medical sciences | General and cellular metabolism. Vitamins | Antihypertensive agents | Pharmacology. Drug treatments | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Hypertension - drug therapy | Male | Hypercholesterolemia - drug therapy | Cause of Death | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipids - blood | Cardiovascular Diseases - epidemiology | Hypertension - complications | Female | Hypercholesterolemia - complications | Aged | Pravastatin - therapeutic use | Evaluation | Hypercholesterolemia | Pravastatin | Drug therapy | Statins | Anticholesteremic agents | Patients | Clinical outcomes | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2009, Volume 301, Issue 1, pp. 39 - 51
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Double-Blind Method | Humans | Middle Aged | Male | Neoplasms - prevention & control | Treatment Outcome | Prostatic Neoplasms - epidemiology | Selenomethionine - therapeutic use | Selenium - therapeutic use | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Vitamin E - therapeutic use | Aged | Prostatic Neoplasms - prevention & control | Dietary Supplements | Neoplasms - epidemiology | Disease prevention | Clinical trials | Selenium | Vitamin E | Prostate cancer | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 05/2010, Volume 33, Issue 5, pp. 983 - 990
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Hypoglycemic Agents - therapeutic use | Multivariate Analysis | Follow-Up Studies | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Risk Factors | Male | Hyperglycemia - drug therapy | Cause of Death | Diabetes Mellitus, Type 2 - mortality | Female | Aged | Hyperglycemia - mortality | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Clinical trials | Pharmaceutical industry | United States | Health aspects | Mortality | Blood pressure | Diabetes | Hypoglycemia | Drug dosages | Pharmaceuticals | Index Medicus | Original Research
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 10/2011, Volume 306, Issue 16, pp. 1798 - 1799
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Clinical Trials as Topic - economics | United States | Health Personnel | Humans | Professional Role | Organizational Policy | Patient Dropouts | Health Knowledge, Attitudes, Practice | Patient Selection | Medical personnel | Clinical trials | Research ethics | Research grants | Management | Laws, regulations and rules | Participants | Retention | Clinical outcomes | Recruitment | Index Medicus | Abridged Index Medicus
Journal Article